Jorge R. Knorrenschild

Marburg An Der Lahn, HE, DE 
Marburg An Der Lahn, HE, DE 

Overview

Jorge Knorrenschild practices practicing medicine in Marburg An Der Lahn, Germany.

His clinical expertise encompasses Esophageal Cancer, Stomach Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Gastroesophageal Junction Cancer.

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Marburg An Der Lahn, HE, Germany
Other Locations
Giessen, HE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Anti-PD-L1 Antibody MEDI4736 in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC). A Multicenter Single-arm Phase II Trial.
Anti-PD-L1 Antibody MEDI4736 in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC). A Multicenter Single-arm Phase II Trial.
Enrollment Status: Completed
Publish Date: October 28, 2025
Intervention Type: Drug
Study Drug: MEDI4736
Study Phase: Phase 2
An Open-label 2:1 Randomized Phase II Study of Panitumumab Plus FOLFOXIRI or FOLFOXIRI Alone as First-line Treatment of Patients With Non-resectable Metastatic Colorectal Cancer and RAS Wild Type
An Open-label 2:1 Randomized Phase II Study of Panitumumab Plus FOLFOXIRI or FOLFOXIRI Alone as First-line Treatment of Patients With Non-resectable Metastatic Colorectal Cancer and RAS Wild Type
Enrollment Status: Completed
Publish Date: June 15, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

13 Total Publications

Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma.
Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma.
Journal: Frontiers in endocrinology
Published: April 28, 2025

Frequently Asked Questions about Jorge R. Knorrenschild

Is Jorge R. Knorrenschild a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jorge R. Knorrenschild is classified as an Experienced expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jorge R. Knorrenschild participate in research or clinical trials?

Yes. Jorge R. Knorrenschild has published 13 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Jorge R. Knorrenschild's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Knorrenschild's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile